PMID- 38426120
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20240302
IS  - 2297-055X (Print)
IS  - 2297-055X (Electronic)
IS  - 2297-055X (Linking)
VI  - 11
DP  - 2024
TI  - Case Report: Resuscitation of patient with tumor-induced acute pulmonary embolism 
      by venoarterial extracorporeal membrane oxygenation.
PG  - 1322387
LID - 10.3389/fcvm.2024.1322387 [doi]
LID - 1322387
AB  - BACKGROUND: Pulmonary embolism is a condition of right cardiac dysfunction due to 
      pulmonary circulation obstruction. Malignant tumor-induced pulmonary embolism, 
      which has a poor therapeutic outcome and a significant impact on hemodynamics, is 
      the cause of sudden death in patients with malignant tumors. CASE DESCRIPTION: A 
      38-year-old female patient, who had a medical history of right renal hamartoma, 
      and right renal space-occupying lesion, was admitted to the hospital. During the 
      procedure to resect the right renal malignancy, the blood pressure and end-tidal 
      carbon dioxide level dropped, and a potential pulmonary embolism was considered 
      as a possibility. After inferior vena cava embolectomy, the hemodynamics in the 
      patient remained unstable. The successful establishment of venoarterial 
      extracorporeal membrane oxygenation (VA-ECMO) resulted in the stabilization of 
      her hemodynamics and ventilation. On Day 2 of VA-ECMO support, her respiration 
      and hemodynamics were relatively stable, and ECMO assistance was successfully 
      terminated following the "pump-controlled retrograde trial off (PCRTO)" test on 
      Day 6. The patient improved gradually after the procedure and was discharged from 
      the hospital after 22 days. CONCLUSION: VA-ECMO can be used as a transitional 
      resuscitation technique for patients with massive pulmonary embolism. It is 
      critical for the perfusion of vital organs and can assist with surgical or 
      interventional treatment, lower right heart pressure, and hemodynamic stability. 
      VA-ECMO has a significant impact on patient prognosis and can reduce the 
      mortality rate.
CI  - (c) 2024 Zhang, Zhang, Li, Guo, Qi, Xing and Wang.
FAU - Zhang, Shuang-Long
AU  - Zhang SL
AD  - Department of Critical Care Medicine, Peking University International Hospital, 
      Beijing, China.
AD  - Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, 
      China.
FAU - Zhang, Qi-Feng
AU  - Zhang QF
AD  - Department of Critical Care Medicine, Peking University International Hospital, 
      Beijing, China.
FAU - Li, Gang
AU  - Li G
AD  - Department of Critical Care Medicine, Peking University International Hospital, 
      Beijing, China.
FAU - Guo, Miao
AU  - Guo M
AD  - Department of Critical Care Medicine, Peking University International Hospital, 
      Beijing, China.
FAU - Qi, Xiao-Xia
AU  - Qi XX
AD  - Department of Critical Care Medicine, Peking University International Hospital, 
      Beijing, China.
FAU - Xing, Xiao-Hui
AU  - Xing XH
AD  - Department of Critical Care Medicine, Peking University International Hospital, 
      Beijing, China.
FAU - Wang, Zheng
AU  - Wang Z
AD  - Department of Critical Care Medicine, Peking University International Hospital, 
      Beijing, China.
LA  - eng
PT  - Case Reports
DEP - 20240215
PL  - Switzerland
TA  - Front Cardiovasc Med
JT  - Frontiers in cardiovascular medicine
JID - 101653388
PMC - PMC10902156
OTO - NOTNLM
OT  - VA-ECMO
OT  - pulmonary embolism
OT  - renal cell carcinoma
OT  - resuscitation
OT  - tumor-induced pulmonary
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2024/03/01 06:44
MHDA- 2024/03/01 06:45
PMCR- 2024/01/01
CRDT- 2024/03/01 03:58
PHST- 2023/10/16 00:00 [received]
PHST- 2024/01/09 00:00 [accepted]
PHST- 2024/03/01 06:45 [medline]
PHST- 2024/03/01 06:44 [pubmed]
PHST- 2024/03/01 03:58 [entrez]
PHST- 2024/01/01 00:00 [pmc-release]
AID - 10.3389/fcvm.2024.1322387 [doi]
PST - epublish
SO  - Front Cardiovasc Med. 2024 Feb 15;11:1322387. doi: 10.3389/fcvm.2024.1322387. 
      eCollection 2024.